高度創傷ケアOTC市場規模、シェア、動向分析レポート：製品別、用途別、流通チャネル別、地域別、セグメント予測、2025年～2033年

高度創傷ケアOTC市場サマリー

高度創傷ケアOTCの世界市場規模は2024年に70億6,000万米ドルと推計され、2033年には160億4,000万米ドルに達すると予測され、2025年から2033年までのCAGRは9.73%で成長します。市場成長の背景には、手術創、外傷、火傷などの急性創傷の増加があり、効果的かつ迅速な創傷管理ソリューションが必要とされています。

世界の交通事故、スポーツ外傷、外科手術の増加により、治癒を早め、感染リスクを軽減する高度なOTC創傷ケア製品の需要が急増しています。Total Family Care Centerが2025年4月に発表したデータによると、米国では年間約1,100万人が急性創傷を経験し、約30万例が病院での治療を必要としています。

市販の高度創傷ケア製品の承認数が増加していることから、今後数年間で市場は大きく成長する見通しです。このような承認により、従来のヘルスケア環境以外でも高度創傷治療への消費者のアクセスが広がっています。

例えば、2024年4月、Vomaris Inc.はOTC用の生体電気包帯PowerHealのFDA認可を取得しました。軽度の切り傷、擦り傷、水疱などの表面的な傷を治療するために設計されたこの絆創膏は、銀と亜鉛から作られたマイクロセル電池を備えています。創傷滲出液、生理食塩水、ハイドロゲルなどの導電性媒体によって活性化されると、マイクロセルは治療用の微小電流を発生し、治癒を早め、感染予防に役立ちます。

軽度の切り傷、裂傷、擦り傷、水疱、褥瘡、糖尿病性足潰瘍、熱傷など、様々なタイプの創傷の発生率が上昇していることから、OTC高度創傷ケア産業の成長が大きく促進されると予想されます。多くの国々で、人口の大部分がこのような傷害の影響を受けており、身近で効果的な家庭用治療ソリューションへの需要が高まっています。例えば、Total Family Care Centerが2025年4月に発表したデータによると、米国では毎年推定1,100万人が急性の創傷に苦しんでおり、入院が必要なのはわずか30万人程度です。このことは、こうしたケースのほとんどがOTC製品を使って自宅で治療されていることを示しており、セルフケアや家庭用に調整された高度な創傷ケアソリューションの大きな市場可能性を物語っています。

さらに、熱傷の発生率は著しく上昇しています。米国熱傷協会（ABA）は、熱傷治療センター全体で2023年に約32,540件の熱傷症例を報告しました。また、2019年から2023年にかけて、米国の38州以上で合計156,073件の熱傷症例が記録されています。このように、軽度の熱傷や糖尿病性足潰瘍を含む様々な創傷タイプの発生率が上昇していることから、高度創傷ケアOTC製品の需要が大幅に増加すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 高度創傷ケアOTC市場の変数、動向、範囲

• 市場系統の見通し
  • 補助市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 高度な創傷ケアOTC市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 高度創傷ケアOTC市場：製品推定・動向分析

• セグメントダッシュボード
• 高度創傷ケアOTC市場：製品変動分析と市場シェア、2024年と2033年
• フォームドレッシング
  • 接着剤
  • 非粘着性
• フィルムドレッシング
• 不織布術後ドレッシング
• ハイドロコロイド
• ハイドロゲルドレッシング
• ワセリンガーゼ
• ハニードレッシング
• その他

第5章 高度創傷ケアOTC市場：用途の推定・動向分析

• セグメントダッシュボード
• 高度創傷ケアOTC市場：用途変動分析と市場シェア、2024年と2033年
• 急性創傷
  • 外科的創傷（手術後の創傷）および外傷（裂傷、擦過傷、切り傷）
  • 火傷（1度のみ）
• 慢性創傷
  • 糖尿病性足潰瘍
  • 褥瘡
  • 静脈性下肢潰瘍
  • その他の慢性創傷

第6章 高度創傷ケアOTC市場：流通チャネルの推定・動向分析

• セグメントダッシュボード
• 高度創傷ケアOTC市場：流通チャネル変動分析と市場シェア、2024年と2033年
• 小売薬局/ドラッグストア
• Eコマース/オンライン薬局/ 健康関連Eコマース
• その他

第7章 高度創傷ケアOTC市場：製品、用途、流通チャネル別の地域推定・動向分析

• 地域展望
• 高度創傷ケアOTC市場：地域変動分析と市場シェア、2024年と2033年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Solventum
  • 3M
  • Medline Industries, LP.
  • PAUL HARTMANN AG
  • Cardinal Health
  • Coloplast Group
  • Convatec Group PLC
  • Smith+Nephew
  • Molnlycke AB
  • Sonoma Pharmaceuticals, Inc.
  • B. Braun SE
  • Beiersdorf
  • DeRoyal Industries, Inc.
  • Vomaris Innovations, Inc.
  • Lavior
  • Dimora Medical
  • Remedium Healthcare Products
• ヒートマップ分析/企業市況分析
• 2024年の企業市場シェア予測分析

List of Tables

• Table 1 List of abbreviation
• Table 2 Global advanced wound care OTC market, by region, 2021 - 2033 (USD Million)
• Table 3 Global advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 4 Global advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 5 Global advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 6 North America advanced wound care OTC market, by country, 2021 - 2033 (USD Million)
• Table 7 North America advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 8 North America advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 9 North America advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 10 U.S. advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 11 U.S. advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 12 U.S. advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 13 Canada advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 14 Canada advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 15 Canada advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 16 Mexico advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 17 Mexico advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 18 Mexico advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 19 Europe advanced wound care OTC market, by country, 2021 - 2033 (USD Million)
• Table 20 Europe advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 21 Europe advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 22 Europe advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 23 UK advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 24 UK advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 25 UK advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 26 Germany advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 27 Germany advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 28 Germany advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 29 France advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 30 France advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 31 France advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 32 Italy advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 33 Italy advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 34 Italy advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 35 Spain advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 36 Spain advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 37 Spain advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 38 Denmark advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 39 Denmark advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 40 Denmark advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 41 Sweden advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 42 Sweden advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 43 Sweden advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 44 Norway advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 45 Norway advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 46 Norway advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 47 Asia Pacific advanced wound care OTC market, by country, 2021 - 2033 (USD Million)
• Table 48 Asia Pacific advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 49 Asia Pacific advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 50 Asia Pacific advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 51 China advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 52 China advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 53 China advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 54 Japan advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 55 Japan advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 56 Japan advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 57 India advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 58 India advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 59 India advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 60 South Korea advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 61 South Korea advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 62 South Korea advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 63 Australia advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 64 Australia advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 65 Australia advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 66 Thailand advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 67 Thailand advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 68 Thailand advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 69 Latin America advanced wound care OTC market, by country, 2021 - 2033 (USD Million)
• Table 70 Latin America advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 71 Latin America advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 72 Latin America advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 73 Brazil advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 74 Brazil advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 75 Brazil advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 76 Argentina advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 77 Argentina advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 78 Argentina advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 79 MEA advanced wound care OTC market, by country, 2021 - 2033 (USD Million)
• Table 80 MEA advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 81 MEA advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 82 MEA advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 83 South Africa advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 84 South Africa advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 85 South Africa advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 86 Saudi Arabia advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 87 Saudi Arabia advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 88 Saudi Arabia advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 89 UAE advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 90 UAE advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 91 UAE advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)
• Table 92 Kuwait advanced wound care OTC market, by product, 2021 - 2033 (USD Million)
• Table 93 Kuwait advanced wound care OTC market, by application, 2021 - 2033 (USD Million)
• Table 94 Kuwait advanced wound care OTC market, by distribution channels, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Information procurement
• Fig. 2 Advanced wound care OTC market segmentation
• Fig. 3 Market research process
• Fig. 4 Information procurement process
• Fig. 5 Primary research pattern
• Fig. 6 Advanced wound care OTC market snapshot, 2024 (USD Million)
• Fig. 7 Segment snapshot, USD Million
• Fig. 8 Competitive landscape snapshot
• Fig. 9 Penetration & growth prospect mapping, by distribution channel
• Fig. 10 Market driver analysis (Current & future impact)
• Fig. 11 Market restraint analysis (Current & future impact)
• Fig. 12 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 13 Foam dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 14 Adhesive market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 15 Non-adhesive foam dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 16 Film dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 17 Non-woven post-operative dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 18 Hydrocolloids market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 Hydrogel dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 Greasy gauzes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Honey dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Other market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Acute wounds market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Surgical (post-surgical wounds) & traumatic wounds (lacerations, abrasions, and cuts) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Burns (only 1st degree burns) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 26 Chronic wounds market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 27 Diabetic foot ulcers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 28 Pressure ulcers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 29 Venous leg ulcers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 Other chronic wounds market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 31 Retail pharmacies/drugstores market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 32 E-commerce/online pharmacies/health e-tailers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 33 Other market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 34 Advanced wound care OTC market: Regional key takeaways (USD Million)
• Fig. 35 Advanced wound care OTC market: Regional outlook, 2023 & 2033 (USD Million)
• Fig. 36 North America advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 37 U.S. advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 38 Canada advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 39 Mexico advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 40 Europe advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 41 UK advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 42 Germany advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 43 France advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 44 Spain advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 45 Italy advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 46 Sweden advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 47 Norway advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 48 Denmark advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 49 Asia Pacific advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 50 China advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 51 Japan advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 52 India advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 53 South Korea advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 54 Australia advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 55 Thailand advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 56 Latin America advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 57 Brazil advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 58 Argentina advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 59 Middle East and Africa advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 60 South Africa advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 61 Saudi Arabia advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 62 UAE advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 63 Kuwait advanced wound care OTC market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 64 List of key emerging companies
• Fig. 65 Company market share analysis, 2024
• Fig. 66 Market differentiators
• Fig. 67 Competitive dashboard analysis
• Fig. 68 Regional network map

Advanced Wound Care OTC Market Summary

The global advanced wound care OTC market size was estimated at USD 7.06 billion in 2024 and is projected to reach USD 16.04 billion by 2033, growing at a CAGR of 9.73% from 2025 to 2033. The growth of the market is attributed to the increasing prevalence of acute wounds such as surgical wounds, traumatic injuries, and burns, which require effective and immediate wound management solutions.

Rising rates of road accidents, sports injuries, and surgical procedures globally have led to a surge in demand for advanced OTC wound care products that promote faster healing and reduce the risk of infection. According to the data published by the Total Family Care Center in April 2025, approximately 11 million individuals in the U.S. experience acute wounds annually, with around 300,000 cases requiring hospital care.

The growing number of regulatory approvals for over-the-counter advanced wound care products is poised to drive significant market growth in the coming years. These approvals are broadening consumer access to advanced wound care treatments outside traditional healthcare settings.

For instance, in April 2024, Vomaris Inc. received FDA clearance for its PowerHeal bioelectric bandage for OTC use. Designed to treat superficial wounds like minor cuts, abrasions, and blisters, the bandage features microcell batteries made from elemental silver and zinc. When activated by a conductive medium such as wound exudate, saline, or hydrogel, the microcells produce therapeutic microcurrents that promote faster healing and help prevent infection.

The rising incidence of various types of wounds-including minor cuts, lacerations, abrasions, blisters, pressure ulcers, diabetic foot ulcers, and burns-is expected to drive growth in the OTC advanced wound care industry significantly. In many countries, large segments of the population are affected by such injuries, fueling demand for accessible and effective at-home treatment solutions. For instance, according to data released by the Total Family Care Center in April 2025, an estimated 11 million people in the U.S. suffer from acute wounds each year, with only about 300,000 requiring hospitalization. This indicates that most of these cases are treated at home with OTC products, underscoring the strong market potential for advanced wound care solutions tailored for self-care and home use.

In addition, the incidence of burns is rising significantly. The American Burn Association (ABA) reported approximately 32,540 burn cases in 2023 across its burn care centers. In addition, from 2019 to 2023, a total of 156,073 burn cases were documented across more than 38 states in the U.S. This rising incidence of various wound types, including minor burns and diabetic foot ulcers, is expected to drive the demand for advanced wound care OTC products significantly.

Global Advanced Wound Care OTC Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global advanced wound care OTC market report based on the product, application, distribution channel, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Foam Dressings
  • Adhesive
  • Non-Adhesive Foam Dressings
• Film Dressings
• Non-Woven Post-Operative Dressings
• Hydrocolloids
• Hydrogel Dressings
• Greasy Gauzes
• Honey Dressings
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Acute Wounds
  • Surgical (post-surgical wounds) & Traumatic Wounds (lacerations, abrasions, and cuts)
  • Burns (only 1st degree burns)
• Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Other Chronic Wounds
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Retail Pharmacies / Drugstores
• E-commerce/Online Pharmacies / Health E-tailers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Purchased database.
• 1.5. GVR's internal database
• 1.6. Secondary sources
• 1.7. Third Party Perspective
• 1.8. Primary research
• 1.9. Details of primary research
• 1.10. Information or Data Analysis
• 1.11. Data analysis models
• 1.12. Market Formulation & Validation
• 1.13. Model Details
• 1.14. Commodity flow analysis (Model 1)
• 1.15. Approach 1: Commodity flow approach
• 1.16. Volume price analysis (Model 2)
• 1.17. Approach 2: Volume price analysis
• 1.18. List of Secondary Sources
• 1.19. List of Primary Sources
• 1.20. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Advanced Wound Care OTC Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing approvals for advanced wound care OTC products
    • 3.2.1.2. Rising burden of wounds
    • 3.2.1.3. Increasing adoption of digital distribution platforms
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product recalls
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Shift from institutional settings to home care
    • 3.2.3.2. Expansion into emerging economies
    • 3.2.3.3. Increasing number of road accidents and injuries
    • 3.2.3.4. Rising awareness about advanced wound care management
    • 3.2.3.5. Expansion opportunity in post-surgical wound management
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Limited indications for OTC use
• 3.3. Advanced Wound Care OTC Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
  • 3.3.3. COVID-19 Impact Analysis
    • 3.3.3.1. Disrupted Breast Pump
    • 3.3.3.2. Obstacles in Breast Pump

Chapter 4. Advanced Wound Care OTC Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Advanced Wound Care OTC Market: Product Movement Analysis & Market Share, 2024 & 2033
• 4.3. Foam Dressings
  • 4.3.1. Foam Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Adhesive
    • 4.3.2.1. Adhesive Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Non-Adhesive
    • 4.3.3.1. Non-Adhesive Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Film Dressings
  • 4.4.1. Film Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Non-Woven Post Operative Dressings
  • 4.5.1. Non-Woven Post Operative Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Hydrocolloids
  • 4.6.1. Hydrocolloids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Hydrogel Dressings
  • 4.7.1. Hydrogel Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Greasy Gauzes
  • 4.8.1. Greasy Gauzes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Honey Dressings
  • 4.9.1. Honey Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Others
  • 4.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Advanced Wound Care OTC Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Advanced Wound Care OTC Market: Application Movement Analysis & Market Share, 2024 & 2033
• 5.3. Acute Wounds
  • 5.3.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Surgical (post-surgical wounds) & Traumatic Wounds (lacerations, abrasions, and cuts)
    • 5.3.2.1. Surgical (post-surgical wounds) & Traumatic Wounds (lacerations, abrasions, and cuts) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.3. Burns (only 1st degree burns)
    • 5.3.3.1. Burns (only 1st degree burns) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Chronic Wounds
  • 5.4.1. Chronic wounds market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Diabetic Foot Ulcers
    • 5.4.2.1. Diabetic foot ulcers market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Pressure Ulcers
    • 5.4.3.1. Pressure ulcers market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.4. Venous Leg Ulcers
    • 5.4.4.1. Venous leg ulcers market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.5. Other Chronic Wounds
    • 5.4.5.1. Other chronic wounds market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Advanced Wound Care OTC Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Advanced Wound Care OTC Market: Distribution Channels Movement Analysis & Market Share, 2024 & 2033
• 6.3. Retail Pharmacies / Drugstores
  • 6.3.1. Retail Pharmacies / Drugstores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. E-commerce/Online Pharmacies / Health E-tailers
  • 6.4.1. E-commerce/Online Pharmacies / Health E-tailers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Others
  • 6.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Advanced Wound Care OTC Market: Regional Estimates & Trend Analysis by Product, Application, Distribution Channel

• 7.1. Regional Outlook
• 7.2. Advanced Wound Care OTC Market: Regional Movement Analysis & Market Share, 2024 & 2033
• 7.3. North America
  • 7.3.1. North America Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Scenario
    • 7.3.2.4. Reimbursement Scenario
    • 7.3.2.5. U.S. Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Scenario
    • 7.3.3.4. Reimbursement Scenario
    • 7.3.3.5. Canada Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Scenario
    • 7.3.4.4. Reimbursement Scenario
    • 7.3.4.5. Mexico Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Reimbursement Scenario
    • 7.4.2.5. UK Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. Reimbursement Scenario
    • 7.4.3.5. Germany Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. Reimbursement Scenario
    • 7.4.4.5. France Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Scenario
    • 7.4.5.4. Reimbursement Scenario
    • 7.4.5.5. Italy Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Scenario
    • 7.4.6.4. Reimbursement Scenario
    • 7.4.6.5. Spain Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Scenario
    • 7.4.7.4. Reimbursement Scenario
    • 7.4.7.5. Denmark Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Scenario
    • 7.4.8.4. Reimbursement Scenario
    • 7.4.8.5. Sweden Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Scenario
    • 7.4.9.4. Reimbursement Scenario
    • 7.4.9.5. Norway Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. Japan Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. China Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. India Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Scenario
    • 7.5.5.4. Reimbursement Scenario
    • 7.5.5.5. South Korea Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Scenario
    • 7.5.6.4. Reimbursement Scenario
    • 7.5.6.5. Australia Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Scenario
    • 7.5.7.4. Reimbursement Scenario
    • 7.5.7.5. Thailand Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. Brazil Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Argentina Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Scenario
    • 7.7.2.4. Reimbursement Scenario
    • 7.7.2.5. South Africa Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Scenario
    • 7.7.3.4. Reimbursement Scenario
    • 7.7.3.5. Saudi Arabia Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Scenario
    • 7.7.4.4. Reimbursement Scenario
    • 7.7.4.5. UAE Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Scenario
    • 7.7.5.4. Reimbursement Scenario
    • 7.7.5.5. Kuwait Advanced Wound Care OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Solventum
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Product Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. 3M
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Product Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. Medline Industries, LP.
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. PAUL HARTMANN AG
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. Cardinal Health
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. Coloplast Group
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. Convatec Group PLC
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Smith+Nephew
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Molnlycke AB
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. Sonoma Pharmaceuticals, Inc.
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Product Benchmarking
    • 8.2.10.4. Strategic Initiatives
  • 8.2.11. B. Braun SE
    • 8.2.11.1. Company Overview
    • 8.2.11.2. Financial Performance
    • 8.2.11.3. Product Benchmarking
    • 8.2.11.4. Strategic Initiatives
  • 8.2.12. Beiersdorf
    • 8.2.12.1. Company Overview
    • 8.2.12.2. Financial Performance
    • 8.2.12.3. Product Benchmarking
    • 8.2.12.4. Strategic Initiatives
  • 8.2.13. DeRoyal Industries, Inc.
    • 8.2.13.1. Company Overview
    • 8.2.13.2. Financial Performance
    • 8.2.13.3. Product Benchmarking
    • 8.2.13.4. Strategic Initiatives
  • 8.2.14. Vomaris Innovations, Inc.
    • 8.2.14.1. Company Overview
    • 8.2.14.2. Financial Performance
    • 8.2.14.3. Product Benchmarking
    • 8.2.14.4. Strategic Initiatives
  • 8.2.15. Lavior
    • 8.2.15.1. Company Overview
    • 8.2.15.2. Financial Performance
    • 8.2.15.3. Product Benchmarking
    • 8.2.15.4. Strategic Initiatives
  • 8.2.16. Dimora Medical
    • 8.2.16.1. Company Overview
    • 8.2.16.2. Financial Performance
    • 8.2.16.3. Product Benchmarking
    • 8.2.16.4. Strategic Initiatives
  • 8.2.17. Remedium Healthcare Products
    • 8.2.17.1. Company Overview
    • 8.2.17.2. Financial Performance
    • 8.2.17.3. Product Benchmarking
    • 8.2.17.4. Strategic Initiatives
• 8.3. Heat Map Analysis/ Company Market Position Analysis
• 8.4. Estimated Company Market Share Analysis, 2024